INSIGHTS ON SOLID DOSE MANUFACTURING

• The Future Of Pharma Packaging Trends, Technologies, And Patient-Centric Solutions

  Pharmaceutical packaging must evolve alongside drug development to ensure stability, safety, and regulatory adherence, utilizing innovative designs to improve therapeutic outcomes and patient accessibility.

• How To Solve Complex Pediatric Dosing Challenges Using Tailored Solutions

  With a partner who understands the science, the regulations, and the real-world demands of dosing children, development can move faster, smarter, and with greater confidence

• Overcoming The Obstacles Of Spray-Dried Dispersion Scale-Up

  SDD scale-up introduces scale-dependent risks that threaten bioavailability, stability, and manufacturability. This white paper details a model-based framework for managing those risks from early feasibility through commercial production.

• Practical Formulation Strategies For Poorly Soluble APIs

  Poor aqueous solubility now defines most drug candidates in development, making early screening and solid-state assessment essential to achieving reliable exposure and avoiding costly reformulation downstream.

• The Importance Of Polymorph Screenings

  5/6/2026

  Discover how systematic polymorph screening reduces development risk, safeguards product performance, and enables confident solid‑form selection across the drug development lifecycle.

• Solubility And Improved Patient Outcomes

  9/9/2026

  Poor solubility poses major development challenges. Innovative formulation technologies and careful excipient selection can improve bioavailability and product performance.

• Compaction Simulation For Tablet Technology Transfer And Scale-Up

  7/15/2026

  Compaction simulation de-risked tech transfer for a 40 mg fexuprazan tablet by defining optimal roller compaction and lubrication parameters before scale-up. Access the full case study to see the data.

• Accelerating An Innovative High Potency Oncology Therapy To Market

  5/13/2026

  Assimilate how disciplined containment, proactive risk management, and collaboration accelerate oncology programs under tight timelines while protecting quality, safety, and global launch readiness.

• Containment Solutions For API Weighing And Dispensing In Pharmaceutical Manufacturing

  9/30/2026

  Potency bands and exposure limits are a starting point for containment selection, not the answer. Quantity, dustiness, transfer method and process energy determine whether a control fits weighing and dispensing.